Summit Therapeutics Inc (SMMT)
19.96
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 14:44
Summit Therapeutics Market Cap: 14.72B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 14.72B |
| November 01, 2024 | 14.00B |
| October 31, 2024 | 13.71B |
| October 30, 2024 | 13.75B |
| October 29, 2024 | 16.10B |
| October 28, 2024 | 16.40B |
| October 25, 2024 | 15.68B |
| October 24, 2024 | 14.35B |
| October 23, 2024 | 14.77B |
| October 22, 2024 | 15.18B |
| October 21, 2024 | 15.11B |
| October 18, 2024 | 15.63B |
| October 17, 2024 | 15.90B |
| October 16, 2024 | 17.29B |
| October 15, 2024 | 16.10B |
| October 14, 2024 | 14.93B |
| October 11, 2024 | 14.71B |
| October 10, 2024 | 13.72B |
| October 09, 2024 | 13.93B |
| October 08, 2024 | 14.51B |
| October 07, 2024 | 13.95B |
| October 04, 2024 | 14.07B |
| October 03, 2024 | 13.72B |
| October 02, 2024 | 14.40B |
| October 01, 2024 | 14.82B |
| Date | Value |
|---|---|
| September 30, 2024 | 16.14B |
| September 27, 2024 | 15.35B |
| September 26, 2024 | 16.76B |
| September 25, 2024 | 16.64B |
| September 24, 2024 | 17.64B |
| September 23, 2024 | 16.10B |
| September 20, 2024 | 17.92B |
| September 19, 2024 | 17.02B |
| September 18, 2024 | 18.05B |
| September 17, 2024 | 19.27B |
| September 16, 2024 | 21.66B |
| September 13, 2024 | 23.47B |
| September 12, 2024 | 20.14B |
| September 11, 2024 | 16.68B |
| September 10, 2024 | 16.64B |
| September 09, 2024 | 13.87B |
| September 06, 2024 | 8.890B |
| September 05, 2024 | 9.057B |
| September 04, 2024 | 8.694B |
| September 03, 2024 | 9.129B |
| August 30, 2024 | 9.405B |
| August 29, 2024 | 9.318B |
| August 28, 2024 | 9.506B |
| August 27, 2024 | 9.760B |
| August 26, 2024 | 9.600B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
46.38M
Minimum
Dec 23 2019
23.47B
Maximum
Sep 13 2024
1.604B
Average
503.76M
Median
Oct 19 2021
Market Cap Benchmarks
| Merck & Co Inc | 257.31B |
| Terns Pharmaceuticals Inc | 498.58M |
| Instil Bio Inc | 176.32M |
| Viking Therapeutics Inc | 7.081B |
| Moderna Inc | 20.33B |
Market Cap Related Metrics
| PS Ratio | 14812.52 |
| Price to Book Value | 33.61 |
| Price | 19.96 |
| Earnings Yield | -1.20% |